• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation.风险因素和合并症对心房颤动发病率的影响
Mater Sociomed. 2017 Dec;29(4):231-236. doi: 10.5455/msm.2017.29.231-236.
2
The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.心房颤动患者中风、心肌梗死、心力衰竭及心源性猝死的累积发病率
Med Arch. 2017 Oct;71(5):316-319. doi: 10.5455/medarh.2017.71.316-319.
3
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
4
Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).CHA2DS2-VASc评分对心房颤动患者中风风险和全因死亡率的预测价值(符合CONSORT标准)
Medicine (Baltimore). 2019 Aug;98(31):e16560. doi: 10.1097/MD.0000000000016560.
5
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
6
Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.心房颤动和心脏瓣膜病患者的卒中与出血风险评分:在全国范围内队列研究中评估“心脏瓣膜病”。
Europace. 2019 Jan 1;21(1):33-40. doi: 10.1093/europace/euy151.
7
Competitive interaction between chronic obstructive pulmonary disease and CHADS-VASc score in predicting incident atrial fibrillation.慢性阻塞性肺疾病与 CHADS-VASc 评分在预测新发心房颤动中的竞争作用。
Int J Cardiol. 2018 Mar 15;255:74-79. doi: 10.1016/j.ijcard.2017.11.036. Epub 2017 Nov 20.
8
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
9
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
10
Relationship among atrial fibrillation, the CHADS-VASc score and ischaemic stroke in patients with coronary artery disease: a propensity score matching study in Hebei, China.河北地区冠心病患者心房颤动、CHADS-VASc 评分与缺血性脑卒中的关系:一项倾向评分匹配研究。
BMC Cardiovasc Disord. 2021 Oct 2;21(1):474. doi: 10.1186/s12872-021-02276-z.

引用本文的文献

1
New-Onset Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting: Is Pulmonary Hypertension a Risk Factor?单纯冠状动脉旁路移植术后新发心房颤动:肺动脉高压是危险因素吗?
Braz J Cardiovasc Surg. 2025 Aug 26;40(5):e20240352. doi: 10.21470/1678-9741-2024-0352.
2
The Impact of Weight Categories on the Association Between Atrial Fibrillation/Flutter and Known Risk Factors: A Nationwide Inpatient Data Analysis.体重类别对心房颤动/扑动与已知危险因素之间关联的影响:一项全国住院患者数据分析。
J Clin Med. 2025 Mar 23;14(7):2187. doi: 10.3390/jcm14072187.
3
Healthcare professionals' views about delivering a rehabilitation programme for individuals living with Atrial Fibrillation: a cross - sectional survey.医疗保健专业人员对为心房颤动患者提供康复计划的看法:一项横断面调查。
BMC Sports Sci Med Rehabil. 2024 Nov 5;16(1):227. doi: 10.1186/s13102-024-01000-6.
4
A Comprehensive Review of Cryptogenic Stroke and Atrial Fibrillation: Real-World Insights Into the Role of Insertable Cardiac Monitors.隐源性卒中与心房颤动综述:可植入式心脏监测器作用的真实世界见解
Cureus. 2024 Sep 28;16(9):e70369. doi: 10.7759/cureus.70369. eCollection 2024 Sep.
5
Effect of Colchicine for Prevention of Recurrent Stroke in Ischemic Stroke Patients with Atrial Fibrillation: A Randomized Double-blinded Placebo-controlled Trial.秋水仙碱对心房颤动缺血性卒中患者预防复发性卒中的作用:一项随机双盲安慰剂对照试验。
Rev Recent Clin Trials. 2025;20(1):59-67. doi: 10.2174/0115748871325292240904060109.
6
Deciphering the Role of microRNAs: Unveiling Clinical Biomarkers and Therapeutic Avenues in Atrial Fibrillation and Associated Stroke-A Systematic Review.解析 microRNAs 的作用:揭示心房颤动及相关卒中的临床生物标志物和治疗新途径——系统综述。
Int J Mol Sci. 2024 May 20;25(10):5568. doi: 10.3390/ijms25105568.
7
Predictive nomogram models for atrial fibrillation in COPD patients: A comprehensive analysis of risk factors and prognosis.慢性阻塞性肺疾病患者心房颤动的预测列线图模型:危险因素与预后的综合分析
Exp Ther Med. 2024 Feb 28;27(4):171. doi: 10.3892/etm.2024.12459. eCollection 2024 Apr.
8
Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care.再灌注治疗背景下急性缺血性卒中合并心房颤动的诊断与管理:优化治疗的见解与策略
J Cardiovasc Dev Dis. 2023 Nov 12;10(11):458. doi: 10.3390/jcdd10110458.
9
Comparison of bleeding risk scores and evaluation of major bleeding predictive factors in patients with major bleeding due to vitamin K antagonist use.维生素K拮抗剂所致大出血患者出血风险评分比较及大出血预测因素评估
Heliyon. 2023 Aug 12;9(8):e19079. doi: 10.1016/j.heliyon.2023.e19079. eCollection 2023 Aug.
10
[Knowledge about warfarin treatment in patients with atrial fibrillation or mechanical prosthetic valves].[心房颤动或机械人工瓣膜患者华法林治疗的相关知识]
Arch Peru Cardiol Cir Cardiovasc. 2022 Dec 31;3(4):188-195. doi: 10.47487/apcyccv.v3i4.256. eCollection 2022 Oct-Dec.

本文引用的文献

1
Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship.慢性阻塞性肺疾病与心房颤动:一种未知的关系。
J Cardiol. 2017 May;69(5):699-705. doi: 10.1016/j.jjcc.2016.12.013. Epub 2017 Feb 8.
2
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).高血压患者的血压控制、心血管风险状况及隐匿性未控制高血压(MUCH)的患病率
Med Arch. 2016 Jul 27;70(4):274-279. doi: 10.5455/medarh.2016.70.274-279.
3
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.心房颤动与心血管疾病、肾脏疾病和死亡风险:系统评价和荟萃分析。
BMJ. 2016 Sep 6;354:i4482. doi: 10.1136/bmj.i4482.
4
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
5
Cardiovascular disease in Europe: epidemiological update 2016.《欧洲心血管疾病:2016年流行病学最新情况》
Eur Heart J. 2016 Nov 7;37(42):3232-3245. doi: 10.1093/eurheartj/ehw334. Epub 2016 Aug 14.
6
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.心房颤动与心肌梗死:病理生理机制的系统评价与评估
J Am Heart Assoc. 2016 May 20;5(5):e003347. doi: 10.1161/JAHA.116.003347.
7
Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study.体力活动、静息心率与心房颤动:特罗姆瑟研究。
Eur Heart J. 2016 Aug 1;37(29):2307-13. doi: 10.1093/eurheartj/ehw059. Epub 2016 Mar 10.
8
The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.慢性肾脏病患者的心房颤动问题
Curr Vasc Pharmacol. 2016;14(3):260-5. doi: 10.2174/1570161114666160115130836.
9
Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly.外周动脉疾病与老年人心房颤动的风险增加有关。
Europace. 2016 Jun;18(6):794-8. doi: 10.1093/europace/euv369. Epub 2015 Nov 20.
10
Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review.心房颤动与非心血管疾病:一项系统综述。
Arq Bras Cardiol. 2015 Nov;105(5):519-26. doi: 10.5935/abc.20150142.

风险因素和合并症对心房颤动发病率的影响

The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation.

作者信息

Naser Nabil, Dilic Mirza, Durak Azra, Kulic Mehmed, Pepic Esad, Smajic Elnur, Kusljugic Zumreta

机构信息

Polyclinic "Dr. Nabil", Sarajevo, Bosnia and Herzegovina.

Clinic for Heart Disease, Blood Vessels and Rheumathism, University Clinical Center Sarajevo, Bosnia and Herzegovina.

出版信息

Mater Sociomed. 2017 Dec;29(4):231-236. doi: 10.5455/msm.2017.29.231-236.

DOI:10.5455/msm.2017.29.231-236
PMID:29284990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5723190/
Abstract

INTRODUCTION

Atrial fibrillation (AF) is the most common form of cardiac arrhythmia in clinical practice and its prevalence increases with age. Patients who develop AF also have cardiovascular risk factors, structural heart disease, and comorbidities, all of which can increase mortality. AF causes a significant economic burden with the increasing trend in AF prevalence and hospitalizations.

RESEARCH OBJECTIVES

The objective of our study is to evaluate the impact of the most common known risk factors on the incidence of atrial fibrillation as an important precursor of cardiac and cerebrovascular morbidity and mortality among our patients in Bosnia and Herzegovina during median follow up period (September 2006 - September 2016). The other objective is to estimate the CHA2DS2-VASc score among our patients based on clinical parameters.

PATIENTS AND METHODS

This study includes 2352 ambulant and hospitalized patients with atrial fibrillation. All patients underwent clinical evaluation which includes thorough assessment for potential risk factors and concomitant conditions in order to determine which of them represent the most common among examinees with atrial fibrillation.

RESULTS

The results show that male gender has slightly more incidence of AF. Obesity and overweight with BMI ≥ 27, cigarettes smoking and sedentary life style are almost present in patients with AF. Arterial hypertension, coronary artery disease, diabetes mellitus, chronic obstructive pulmonary disease, chronic renal dysfunction, structural and valvular heart disease and peripheral vascular disease are the most common comorbidities among our patients. The mean CHA2DS2-VASc score was 3.2±1.4 and the mean HAS-BLED score was 2.1±1.2.

CONCLUSION

Atrial fibrillation is the most common sustained cardiac rhythm disorder. The study shows that obesity, alcohol consumption, smoking cigarettes and dyslipidemia can be considered as triggers and predisposing factors for appearance of AF. Arterial hypertension, coronary artery disease, chronic obstructive pulmonary disease, diabetes mellitus, Peripheral vascular disease and chronic kidney disease are playing important role in developing of AF.

摘要

引言

心房颤动(AF)是临床实践中最常见的心律失常形式,其患病率随年龄增长而增加。发生房颤的患者还伴有心血管危险因素、结构性心脏病和合并症,所有这些都会增加死亡率。随着房颤患病率和住院率呈上升趋势,房颤造成了巨大的经济负担。

研究目的

我们研究的目的是评估最常见的已知危险因素对心房颤动发病率的影响,心房颤动是波斯尼亚和黑塞哥维那患者在中位随访期(2006年9月至2016年9月)中心脑血管发病和死亡的重要先兆。另一个目的是根据临床参数估计我们患者的CHA2DS2-VASc评分。

患者与方法

本研究纳入2352例门诊和住院的心房颤动患者。所有患者均接受了临床评估,包括对潜在危险因素和伴随疾病的全面评估,以确定哪些因素在房颤患者中最为常见。

结果

结果显示,男性房颤发病率略高。房颤患者中几乎都存在肥胖和超重(BMI≥27)、吸烟和久坐的生活方式。动脉高血压、冠状动脉疾病、糖尿病、慢性阻塞性肺疾病、慢性肾功能不全、结构性和瓣膜性心脏病以及外周血管疾病是我们患者中最常见的合并症。平均CHA2DS2-VASc评分为3.2±1.4,平均HAS-BLED评分为2.1±1.2。

结论

心房颤动是最常见的持续性心律失常。研究表明,肥胖、饮酒、吸烟和血脂异常可被视为房颤出现的触发因素和易感因素。动脉高血压、冠状动脉疾病、慢性阻塞性肺疾病、糖尿病、外周血管疾病和慢性肾病在房颤的发生发展中起重要作用。